1. Home
  2. GROY vs FLGT Comparison

GROY vs FLGT Comparison

Compare GROY & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GROY

Gold Royalty Corp.

HOLD

Current Price

$4.20

Market Cap

938.2M

Sector

N/A

ML Signal

HOLD

Logo Fulgent Genetics Inc.

FLGT

Fulgent Genetics Inc.

HOLD

Current Price

$26.81

Market Cap

867.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GROY
FLGT
Founded
2020
2011
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
938.2M
867.4M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
GROY
FLGT
Price
$4.20
$26.81
Analyst Decision
Strong Buy
Buy
Analyst Count
5
3
Target Price
$5.00
$28.33
AVG Volume (30 Days)
3.4M
206.0K
Earning Date
11-05-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,464,000.00
$315,549,000.00
Revenue This Year
$72.11
$16.84
Revenue Next Year
$100.63
$9.74
P/E Ratio
N/A
N/A
Revenue Growth
86.30
13.61
52 Week Low
$1.16
$14.57
52 Week High
$4.49
$31.04

Technical Indicators

Market Signals
Indicator
GROY
FLGT
Relative Strength Index (RSI) 58.10 42.88
Support Level $4.08 $26.63
Resistance Level $4.23 $28.26
Average True Range (ATR) 0.18 0.62
MACD -0.00 -0.21
Stochastic Oscillator 88.44 4.59

Price Performance

Historical Comparison
GROY
FLGT

About GROY Gold Royalty Corp.

Gold Royalty Corp is a precious metals-focused royalty and mineral streaming company. The company offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests. The company derives maximum revenue from Canada.

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Share on Social Networks: